Skip to main navigation
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Contact
  • Programs
    • HBV
    • Pipeline
  • Patients
    • Commitment
    • Clinical Trials
    • Resources
  • Sustainability
    • Overview
    • Business Ethics
    • Access to Health Care
    • Human Capital
    • Environment, Health and Safety
  • Collaborations
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
  • Careers
    • Culture
    • Benefits
    • Opportunities
On the
  • Press Releases
  • Events & Presentations

Event Details

AASLD – The Liver Meeting 2022

Nov 4 - Nov 8, 2022

Supporting Materials

Poster – ABI-4334 – Preclinical characterization: Accelerates capsid assembly and inhibits cccDNA formation via multiple pathways 513.1 KB
Poster – HBV and HDV Entry Inhibitor Program – Preclinical characterization 1.1 MB
Late-breaking poster – Interferon Small Molecule Receptor (IFNAR) Agonist Program – Preclinical characterization 1 MB
Late-breaking poster – Vebicorvir – Interim data from open label Study 204 evaluating vebicorvir, NrtI and AB-729 combination 603.1 KB
Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds
Search Investors

Contact Us

833.509.4583
info@assemblybio.com
LinkedIn
About Programs Patients Collaborations Investors Careers

© 2023 Assembly Biosciences, Inc.